Header Image

Soumission pour les présentations orales et les affiches individuelles

Individual Oral, Poster, and Brag N Steal Submission Guidelines

To submit a proposal, please read and adhere to the submission guidelines below and submit via the online submission portal.  You will be required to create an account if you do not have one already.

It is recommended that submitters do not wait until the last day to submit and that submitters ensure they have access in advance.  Submitters are able to start their submission and leave it in draft mode before submitting to ensure access.

Deadline: February 12, 2026

Submission Directions

  • Prepare to provide/answer the following:
    • Your contact name, affiliation/institution name and email address
    • Title of the submission (max 255 characters). Please use sentence case only for the title (capitalize the first letter of the title and lower case for all other letters unless required) and do not include a period (.) at the end of the title.
    • Desired presentation format (Oral, Poster, Oral and/or Poster, Brag N Steal Oral, Brag N Steal Poster, Brag N Steal Oral and/or Poster) – Highest ranked submissions will be invited to present orally in addition to their poster.
      • All approved submissions will be offered a poster, with some selected to do an oral presentation.
      • All Brag N Steal submissions will be considered for an oral presentation, only a select group will be approved. All others will be offered a poster.
    • For Brag N Steal
      • Please describe why your team should be selected to present at the Brag and Steal session (max 3000 characters).
        • Include details of a specific toolkit, process, assessment, or clinical/research innovation or improvement that has positively impacted outcomes at your site.
        • Explain how this approach is effective, adaptable, and ready to be shared with other teams, and how it could benefit attendees by being implemented at their own sites.
        • What makes your innovation worth « bragging » about, and why should others « steal » it for their own practice or research?

 

  • For Oral & Posters:
    • A structured abstract that includes background, methodology, results and conclusion (max 3000 characters).
      • Background: This section should briefly describe relevant background information and the purpose of the study.
      • Methods: This section should briefly describe what research was done, how it was completed and who was involved.
      • Results: This section should describe what findings resulted from the study with relevant details (e.g., statistics), as appropriate.
      • Conclusion: This section should briefly summarize the implications of the results and why it is important.
    • The names, affiliation/institution name, and email address for each of the corresponding authors
    • Name of the presenting author

The submitting author will be asked to confirm:

  • that all co-authors are aware of the content of the abstract and agree to its submission as submitted;
  • that all authors consent to publications of the submitted abstract related to the Canadian Stroke Congress 2026 (e.g., on the website, program materials, etc.);
  • that all authors consent to the publication of the abstract in a scientific journal (if publication of the abstract is approved)

The submitting author will be asked the following questions:

  • have you read the submission guidelines?
  • confirm that the material has not been presented at another national or international conference in the past
  • indicate the current position for the presenting author (a drop down list will be provided)

Please note, presenting authors must be registered participants and all abstracts must be submitted and presented in English.

.

HOT TOPICS & AREAS OF INTEREST FOR SYMPOSIUM SUBMISSIONS

We encourage submissions that highlight innovation, interdisciplinary collaboration, equity, lived experience, and advances across the stroke care continuum. Proposals that integrate multiple domains (e.g., mechanistic + clinical, data science + lived experience, systems + education) are especially welcome.

Below is a non-exhaustive list of priority themes to help guide Symposia submissions. Technical submission guidelines follow this list.

  1. Preclinical & Mechanistic Science- Symposia that deepen understanding of the biological foundations of stroke, neural repair, and recovery.
  2. Clinical & Intervention Research –Symposia addressing evidence-based approaches to improving patient outcomes post-stroke.
  3. Population Health & Stroke Risk Across the Lifespan – Topics that explore upstream prevention, equity, and long-term outcomes at a population level.
  4. Quality Improvement, Implementation Science & Patient Safety – Symposia that emphasize systems-level learning, continuous improvement, and safe care.
  5. Data Science, AI, and Emerging Technologies – Innovations that bring computational power, AI, and digital solutions into stroke care.
  6. Health Systems, Policy, & Equity – Symposia exploring policy, structures, and innovations that enable high-quality stroke care for all Canadians.
  7. PWLE, Family, & Community Engagement – Topics that prioritize the voice and leadership of people with lived experience (PWLE).

Note: Symposia in this category should demonstrate meaningful PWLE involvement at all stages of development and presentation.

  1. Education, Training & Knowledge Translation – Symposia focusing on strengthening stroke competencies, workforce development, and training innovation.
  2. Cross-Cutting “Hot Topics” Relevant Across Categories – These themes can be woven through any submission and are particularly encouraged.

 

Symposia Submission Guidelines

Symposia are a set of talks providing an in-depth perspective on individual research areas/topics. Symposia sessions may be comprised of 3 talks with a discussant or 4 talks (no discussant). All symposia must be chaired by the submitting author.

Note: symposium presentations should be 45 minutes in length + 15 minutes for Q & A. The session should not exceed 60 minutes. Speakers are required to present in person at the Congress (exceptions maybe granted for medical limitations).

To submit a proposal:

  • please read and adhere to the submission guidelines
  • submit via the online submission portal
  • create an account if you do not have one already
  • it is recommended that submitters do not wait until the last day to submit and that submitters ensure they have access in advance
  • Submitters are able to start their submission and leave it in draft mode before submitting to ensure access

Deadline: February 12, 2026

Submission Directions

  • Prepare to answer the following questions and/or include the following items:
    • Your contact name, affiliation/institution name and email address
    • Title of the submission (max 255 characters/50 words). Please use sentence case only for the title (capitalize the first letter of the title and lower case for all other letters unless required) and do not include a period (.) at the end of the title
    • Keywords: minimum of 1; maximum of 2
    • Format
      • Symposium Overview:
        Provide a concise summary of the proposed symposium, including its scope, relevance, and intended audience (maximum 250 words).
        (Maximum 2,000 characters)
  • The name, affiliation/institution name, and email address for the moderator(s)
  • The name, affiliation/institution name, and email address for the speakers

 

  • The submitting author will be asked to confirm:
    • The submission has been approved by all authors
    • They have read the submission guidelines
    • The material has not been presented at another national or international conference in the past

Additional Key Symposium Information

  • Please describe the novel concepts, findings, or perspectives that will be presented and explain their significance to the field of stroke and/or vascular cognitive impairment research or care.
    (Maximum 2,000 characters)
  • Educational Objective 1:
    Please state a clear learning objective that attendees will achieve by participating in this symposium.
    (Maximum 2,000 characters)
  • Educational Objective 2:
    Please state an additional learning objective that attendees will achieve by participating in this symposium.
    (Maximum 2,000 characters)
  • Educational Objective 3:
    Please state a third learning objective that attendees will achieve by participating in this symposium.
    (Maximum 2,000 characters)
  • Proposed Speaker Schedule:
    Please list all proposed speakers, their affiliations, email addresses, presentation titles (if available), and the anticipated order and duration of presentations.

Please note, presenting authors must be registered participants and all symposia must be submitted and presented in English.

HOT TOPICS & AREAS OF INTEREST FOR SYMPOSIUM SUBMISSIONS – DETAILED DESCRIPTIONS

Below is a non-exhaustive list of priority themes to help guide Symposia submissions. Technical submission guidelines follow this list.

  1. Preclinical & Mechanistic Science

Symposia that deepen understanding of the biological foundations of stroke, neural repair, and recovery, including:

  • Neurovascular biology; cerebral blood flow regulation; neuroinflammation
  • Mechanisms of neuroplasticity, diaschisis, and circuit reorganization
  • Biomarkers of recovery (imaging, electrophysiology, genetics, proteomics, metabolomics)
  • Animal models of ischemic stroke, hemorrhagic stroke, and vascular dementia
  • Early-phase therapeutic discovery (small molecules, neuromodulation, biologics)
  • Sex differences and mechanisms contributing to disparities in stroke outcomes
  1. Clinical & Intervention Research

Symposia addressing evidence-based approaches to improving patient outcomes post-stroke, including:

  • Acute therapies (thrombolysis, EVT optimization, personalized reperfusion strategies)
  • Stroke unit care, early supported discharge, and intensive rehabilitation models
  • Novel neurorehabilitation interventions (robotics, VR/AR, digital therapeutics)
  • Aphasia treatment innovation; motor recovery; gait, balance, and functional mobility
  • Fatigue, post-stroke depression, anxiety, sleep, and cognitive-communication therapies
  • Trials evaluating dose, timing, and intensity of rehabilitation
  • Precision rehabilitation or personalized medicine approaches
  1. Population Health & Stroke Risk Across the Lifespan

Topics that explore upstream prevention, equity, and long-term outcomes at a population level:

  • Social determinants of health, rural/remote access, and Indigenous health equity
  • Environmental and lifestyle risk factors; community-based prevention
  • Health behaviour change interventions and implementation
  • Atrial fibrillation, hypertension, diabetes, and metabolic risk stratification
  • Life-course approaches: pediatric stroke, young adult stroke, aging with stroke
  • Long-term survivorship, reintegration, and chronic disease management
  1. Quality Improvement, Implementation Science & Patient Safety

Symposia that emphasize systems-level learning, continuous improvement, and safe care:

  • Stroke pathway redesign and workflow optimization across settings
  • Door-to-needle/time-to-treatment reduction strategies
  • Implementation trials, pragmatic clinical trials, and audit-feedback systems
  • Rehab service delivery improvement and continuity across transitions of care
  • Patient safety, human factors, and error-prevention initiatives
  • Provincial/national benchmarking and quality indicator development
  1. Data Science, AI, and Emerging Technologies

Innovations that bring computational power, AI, and digital solutions into stroke care:

  • Machine learning for diagnosis, prognosis, imaging, and clinical decision support
  • Large-scale data integration (EHR, registries, administrative datasets, wearables)
  • Predictive analytics for recovery trajectories or secondary prevention
  • Real-time monitoring via digital biomarkers, sensors, apps, and remote platforms
  • Federated learning, privacy-preserving analytics, and ethical use of AI
  • Digital twins, simulation modelling, and risk stratification tools
  1. Health Systems, Policy, & Equity

Symposia exploring policy, structures, and innovations that enable high-quality stroke care for all Canadians:

  • Canadian Stroke Best Practices development and implementation
  • Workforce challenges, interprofessional collaboration, and team-based care
  • Equity-centred systems design, gender-informed policy, and culturally safe care
  • Decentralized clinical trials and national research platforms
  • Resource allocation, cost-effectiveness, and sustainability in stroke services
  • Emergency medical services and prehospital stroke pathways
  1. PWLE, Family, & Community Engagement

Topics that prioritize the voice and leadership of people with lived experience (PWLE):

  • Co-design of research, technology, guidelines, and care pathways
  • Lived experience panels on recovery, navigation, caregiving, long-term outcomes
  • Peer support networks, community partnerships, and co-produced innovations
  • Culturally grounded and community-driven healing and rehabilitation

Note: Symposia in this category should demonstrate meaningful PWLE involvement at all stages of development and presentation.

  1. Education, Training & Knowledge Translation

Symposia focusing on strengthening stroke competencies, workforce development, and training innovation:

  • Simulation-based learning, competency-based education, and interprofessional curricula
  • KT science: scaling research to practice, adoption of clinical guidelines
  • Supporting trainees, early-career researchers, and clinician-scientists
  • Public education campaigns and health literacy innovations
  • Use of multimedia, digital platforms, and creative approaches to dissemination
  1. Cross-Cutting “Hot Topics” Relevant Across Categories

These themes can be woven through any submission and are particularly encouraged:

  • Equity, diversity, inclusion, and accessibility (EDIA)
  • Climate change, environmental sustainability, and stroke risk
  • Novel trial methodology (adaptive designs, hybrid trials, platform trials)
  • Lived-experience leadership and co-production models
  • Rural, remote, and northern health innovation
  • Long COVID–related cerebrovascular challenges
  • Brain health, dementia prevention, and vascular cognitive impairment
  • Intersections of mental health, stroke, and neuropsychiatry